While the studies on these systems have proven them to be effective in diagnosing and treating COVID in specific cohorts, the varying settings in which they were used can make it difficult to derive definitive conclusions on their efficacy.

Reviewing data from several studies, researchers wrote that vericiguat (Verquvo) could potentially "become a breakthrough in the treatment of heart failure." 

The newly formed group, the American Medical Manufacturers Association, includes Altor Safety, Aquaspersions USA, Blue Star NBR, Lutema, Ochsner Health, Premium-PPE, SafeSource Direct, United Safety Technology and Vizient as its initial members.

A new study utilizing multi-organ MRI scans recently identified organ impairment in 62% of COVID long haulers six months after their initial diagnosis; 29% of these individuals continued to display damage in at least one organ at the 12-month mark.

Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward? 

Quantifiable features of medical images such as pixel intensity, arrangement, color and texture—in a word, radiomics—can help radiologists improve diagnostic accuracy.

Patients who are vaccinated at the time of their COVID-19 diagnosis appear to face a lower risk of new-onset type 2 diabetes than patients who are not vaccinated. 

According to new research published in the American Journal of Cardiology, complex CAD appears to affect long-term TAVR outcomes much more for women than it does for men.